111 Capital’s Eli Lilly LLY Stock Holding History

111 Capital’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.51M	Sell	2,169 -1,595	-42%	-$1.88M	0.37%	54
2026 Q2	$4.51M	Buy	3,764 +978	+35%	+$999K	0.78%	23
2026 Q1	$2.56M	Buy	2,786 +756	+37%	+$766K	0.63%	27
2025 Q4	$2.18M	Buy	2,030 +1,376	+210%	+$1.32M	0.48%	32
2025 Q3	$499K	Sell	654 -864	-57%	-$643K	0.09%	217
2025 Q2	$1.18M	Sell	1,518 -1,403	-48%	-$1.09M	0.2%	110
2025 Q1	$2.41M	Buy	+2,921	New	+$2.43M	0.47%	38

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

111 Capital's LLY Position: Q3 2026 in Review

111 Capital reduced its Eli Lilly (LLY) stake by 42% in Q3 2026, selling an estimated $1.88M and leaving 2,169 shares worth $2.51M. The position accounts for 0.37% of the portfolio, ranked #54.

111 Capital first reported a position in LLY in Q1 2025 and has held it in 7 quarters since. The position peaked at $4.51M in Q2 2026. 2,846 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

111 Capital held 2,169 shares of Eli Lilly worth $2.51M as of Q3 2026.
111 Capital sold 1,595 Eli Lilly shares in Q3 2026, an estimated $1.88M.
Eli Lilly made up 0.37% of 111 Capital's portfolio in Q3 2026, its #54 holding.
111 Capital first reported a position in Eli Lilly in Q1 2025 and has held it in 7 quarters since.
111 Capital's Eli Lilly position peaked at $4.51M in Q2 2026.
2,846 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on 111 Capital's 13F filing for Q3 2026, filed 3 Nov 2026.